Epidemiology and Mortality-Associated Factors of Invasive Fungal Disease in Elderly Patients: A 20-Year Retrospective Study from Southern China

References

• Dwyer LL, Harris-Kojetin LD, Valverde RH, et al. Infections in long-term care populations in the United States. J Am Geriatr Soc. 2013;61(3):342–349. doi:10.1111/jgs.2013.61.issue-323496650
   PubMed Web of Science ®Google Scholar
• Montecino-Rodriguez E, Berent-Maoz B, Dorshkind K. Causes, consequences, and reversal of immune system aging. J Clin Invest. 2013;123(3):958–965. doi:10.1172/JCI6409623454758
   PubMed Web of Science ®Google Scholar
• Bassetti M, Righi E, Ansaldi F, et al. A multicenter multinational study of abdominal candidiasis: epidemiology, outcomes and predictors of mortality. Intensive Care Med. 2015;41(9):1601–1610. doi:10.1007/s00134-015-3866-226077063
   PubMed Web of Science ®Google Scholar
• Ramos-Martínez A, Vicente-López N, Sánchez-Romero I, et al. Epidemiology and prognosis of candidaemia in elderly patients. Mycoses. 2017;60(12):808–817. doi:10.1111/myc.2017.60.issue-1228836309
   PubMed Web of Science ®Google Scholar
• Martin GS, Mannino DM, Eaton S, Moss M. The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med. 2003;348(16):1546–1554. doi:10.1056/NEJMoa02213912700374
   PubMed Web of Science ®Google Scholar
• Li Y, Fang W, Jiang W, et al. Cryptococcosis in patients with diabetes mellitus II in mainland China: 1993–2015. Mycoses. 2017;60(11):706–713. doi:10.1111/myc.2017.60.issue-1128857298
   PubMed Web of Science ®Google Scholar
• Roden MM, Zaoutis TE, Buchanan WL, et al. Epidemiology and outcome of zygomycosis: a review of 929 reported cases. Clin Infect Dis. 2005;41(5):634–653.16080086
   PubMed Web of Science ®Google Scholar
• Ascioglu S, Rex JH, de Pauw B, et al. Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus. Clin Infect Dis. 2002;34(1):7–14. doi:10.1086/32333511731939
   PubMed Web of Science ®Google Scholar
• De Pauw B, Walsh TJ, Donnelly JP, et al. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses. Clin Infect Dis. 2008;46(12):1813–1821. doi:10.1086/58866018462102
   PubMed Web of Science ®Google Scholar
• Scientific working group. The diagnosis and treatment of Candidiasis: the expert consensus. Clin J Infect Chemother. 2011;11(2):81–95. Chinese
   Google Scholar
• Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2012 Clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int Suppl. 2013;3(1):1–150.
   Web of Science ®Google Scholar
• Joint Committee for Guideline Revision. 2018 Chinese guidelines for prevention and treatment of Hypertension-A report of the revision committee of chinese guidelines for prevention and treatment of hypertension. J Geriatr Cardiol. 2019;16(3):182–241. doi:10.11909/j.issn.1671-5411.2019.03.01431080465
   PubMedGoogle Scholar
• Global initiative for chronic Obstructive Lung Disease. Global strategy for the diagnosis, management and prevention of COPD, 2018 Available from: https://www.goldcopd.org/. Accessed 717, 2018.
   Google Scholar
• Vogelmeier CF, Criner GJ, Martinez FJ, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease 2017 report. GOLD executive summary. Am J Respir Crit Care Med. 2017;195(5):557–582. doi:10.1164/rccm.201701-0218PP28128970
   PubMed Web of Science ®Google Scholar
• Chinese Medical Association. Chinese guideline for type 2 diabetes mellitus. Chin J Diabetes. 2014;22(8):2–42. Chinese
   Google Scholar
• Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373–383. doi:10.1016/0021-9681(87)90171-83558716
   PubMedGoogle Scholar
• Patterson TF, Thompson GR 3rd, Denning DW, et al. Practice guidelines for the diagnosis and management of aspergillosis: 2016 update by the Infectious Diseases Society of America. Clin Infect Dis. 2016;63(4):e1–e60. doi:10.1093/cid/ciw32627365388
   PubMed Web of Science ®Google Scholar
• Pfaller MA, Diekema DJ. Epidemiology of invasive candidiasis: a persistent public health problem. Clin Microbiol Rev. 2007;20(1):133–163. doi:10.1128/CMR.00029-0617223626
   PubMed Web of Science ®Google Scholar
• National Cancer Institute. Common terminology criteria for adverse events version 3.0. Available from: https://ctep.cancer.gov/protocoldevelopment/electronic_applications/docs/ctcaev3.pdf. Accessed March 31, 2003.
   Google Scholar
• Zhang ZN, Shen T. Diagnosis and Treatment of Blood Diseases. 3nd ed Beijing: Science Press; 2007 Chinese.
   Google Scholar
• Wrench C, Belchamber KBR, Bercusson A, et al. Reduced clearance of fungal spores by chronic obstructive pulmonary disease GM-CSF- and M-CSF-derived macrophages. Am J Respir Cell Mol Biol. 2018;58(2):271–273. doi:10.1165/rcmb.2017-0351LE29388829
   PubMed Web of Science ®Google Scholar
• Gosiewski T, Salamon D, Szopa M, et al. Quantitative evaluation of fungi of the genus Candida in the feces of adult patients with type 1 and 2 diabetes-A pilot study. Gut Pathog. 2014;6(1):43. doi:10.1186/s13099-014-0043-z25328543
   PubMed Web of Science ®Google Scholar
• Tumbarello M, Fiori B, Trecarichi EM, et al. Risk factors and outcomes of candidemia caused by biofilm-forming isolates in a tertiary care hospital. PLoS One. 2012;7(3):e33705. doi:10.1371/journal.pone.003370522479431
   PubMedGoogle Scholar
• Wuthrich M, Deepe GS, Klein B. Adaptive immunity to fungi. Annu Rev Immunol. 2012;30:115–148. doi:10.1146/annurev-immunol-020711-07495822224780
   PubMed Web of Science ®Google Scholar
• Leibundgut-landmann S, Wothrich M, Hohl TM. Immunity to fungi. Curr Opin Immunol. 2012;24(4):449–458. doi:10.1016/j.coi.2012.04.00722613091
   PubMed Web of Science ®Google Scholar
• Webster RG. Immunity to influenza in the elderly. Vaccine. 2000;18(16):1686–1689. doi:10.1016/S0264-410X(99)00507-110689149
   PubMed Web of Science ®Google Scholar
• Nagel JE, Chopra RK, Chrest FJ, et al. Decreased proliferation, interleukin 2 synthesis, and interleukin 2 receptor expression are accompanied by decreased mRNA expression in phytohemagglutinin-stimulated cells from elderly donors. J Clin Invest. 1988;81(4):1096–1102. doi:10.1172/JCI1134223127423
   PubMed Web of Science ®Google Scholar
• Andes DR, Safdar N, Baddley JW, et al. Impact of treatment strategy on outcomes in patients with candidemia and other forms of invasive candidiasis: a patient-level quantitative review of randomized trials. Clin Infect Dis. 2012;54(8):1110–1122. doi:10.1093/cid/cis02122412055
   PubMed Web of Science ®Google Scholar
• Girois SB, Chapuis F, Decullier E, Revol BG. Adverse effects of antifungal therapies in invasive fungal infections: review and meta-analysis. Eur J Clin Microbiol Infect Dis. 2006;25(2):138–149. doi:10.1007/s10096-005-0080-016622909
   PubMed Web of Science ®Google Scholar
• Scott LJ. Micafungin: a review of its use in the prophylaxis and treatment of invasive Candida infections. Drugs. 2012;72(16):2141–2165. doi:10.2165/11209970-000000000-0000023083111
   PubMed Web of Science ®Google Scholar
• Douglas LJ. Candida biofilms and their role in infection. Trends Microbiol. 2003;11(1):30–36. doi:10.1016/S0966-842X(02)00002-112526852
   PubMed Web of Science ®Google Scholar